Surgical Innovations Group (LSE:SUN) Other Current Liabilities: £0.26 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Surgical Innovations Group Other Current Liabilities?

Surgical Innovations Group LSE:SUN Other Current Liabilities is £0.26 Mil as of Dec. 2025. The stock has 2 warning signs investors should review.

Surgical Innovations Group's other current liabilities for the quarter that ended in Dec. 2025 was £0.26 Mil.

Surgical Innovations Group's quarterly other current liabilities declined from Dec. 2024 (£0.69 Mil) to Jun. 2025 (£0.36 Mil) and declined from Jun. 2025 (£0.36 Mil) to Dec. 2025 (£0.26 Mil).

Surgical Innovations Group's annual other current liabilities increased from Dec. 2023 (£0.38 Mil) to Dec. 2024 (£0.69 Mil) but then declined from Dec. 2024 (£0.69 Mil) to Dec. 2025 (£0.26 Mil).

Surgical Innovations Group Other Current Liabilities Related Terms

Surgical Innovations Group Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Surgical Innovations Group's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Surgical Innovations Group Other Current Liabilities Chart

Surgical Innovations Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.49 0.42 0.38 0.69 0.26

Surgical Innovations Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.38 0.55 0.69 0.36 0.26

Surgical Innovations Group Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of £0.26 Mil mean?
Surgical Innovations Group (LSE:SUN) has a Other Current Liabilities of £0.26 Mil as of Dec. 2025. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Surgical Innovations Group.
Is Surgical Innovations Group's Other Current Liabilities too high?
Surgical Innovations Group's current Other Current Liabilities is £0.26 Mil.
How does Surgical Innovations Group's Other Current Liabilities compare to ABT and SYK?
Surgical Innovations Group's Other Current Liabilities of £0.26 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Devices & Instruments company?
A good Other Current Liabilities depends on the Medical Devices & Instruments industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Surgical Innovations Group. Surgical Innovations Group's current Other Current Liabilities is £0.26 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgical Innovations Group stock overvalued right now?
Surgical Innovations Group (LSE:SUN) has a current Other Current Liabilities of £0.26 Mil. The current Other Current Liabilities is £0.26 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Surgical Innovations Group (LSE:SUN), the current Other Current Liabilities is £0.26 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Surgical Innovations Group Business Description

Address Clayton Wood House, 6 Clayton Wood Bank, Leeds, GBR, LS16 6QZ
Surgical Innovations Group PLC is involved in the design, development, manufacture, and sale of devices for use in minimally invasive surgery (SI Brand), along with its label products through original equipment manufacturer (OEM) relationships, including precision engineering markets (PE). The Company's operating segments are SI Brand, OEM, and Distribution. The majority of its revenue is generated from the SI Brand segment, which is involved in the research, development, manufacture, and distribution of SI-branded minimally invasive devices. Geographically, the group derives a majority of its revenue from the United Kingdom, followed by Europe, the United States, the Asia-Pacific region, and the Rest of the world.